INS and metabolic disease: Prior studies have linked ribosomal protein dysregulation—especially RPL11—to metabolic disorders: RPL11 downregulation in pancreatic β-cells impairs insulin secretion (6), while ribosomal stress in endothelial cells exacerbates diabetic macroangiopathy (7).